U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

There is one exact (name or code) match for metharbital

 
Status:
US Previously Marketed
Source:
Gemonil by Abbott
(1952)
Source URL:
First approved in 1952
Source:
Gemonil by Abbott
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Methbarbital is a barbiturate anticonvulsant, discovered by Merck in 1905. It was introduced to market for treatment of epolepsy by Abbott in 1952, and discontinued in 1990.
Status:
US Previously Marketed
Source:
Gemonil by Abbott
(1952)
Source URL:
First approved in 1952
Source:
Gemonil by Abbott
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Methbarbital is a barbiturate anticonvulsant, discovered by Merck in 1905. It was introduced to market for treatment of epolepsy by Abbott in 1952, and discontinued in 1990.
Status:
US Previously Marketed
Source:
Gemonil by Abbott
(1952)
Source URL:
First approved in 1952
Source:
Gemonil by Abbott
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Methbarbital is a barbiturate anticonvulsant, discovered by Merck in 1905. It was introduced to market for treatment of epolepsy by Abbott in 1952, and discontinued in 1990.